return2ozma@lemmy.world to News@lemmy.world · 7 months agoOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comexternal-linkmessage-square157fedilinkarrow-up1617arrow-down117cross-posted to: piracy@lemmy.dbzer0.comhackernews@lemmy.smeargle.fans
arrow-up1600arrow-down1external-linkOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comreturn2ozma@lemmy.world to News@lemmy.world · 7 months agomessage-square157fedilinkcross-posted to: piracy@lemmy.dbzer0.comhackernews@lemmy.smeargle.fans
minus-squaremelpomenesclevage@lemm.eelinkfedilinkarrow-up1·7 months agoTo be fair, drug development is pretty expensive. A lot of the budgets for it are public-because it happens at public institutions.
To be fair, drug development is pretty expensive. A lot of the budgets for it are public-because it happens at public institutions.